FGF1 and myocardial infarction: Treatment of these patches with FGF1 and an inhibitor of GSK3 (CHIR99021), which activates Wnt signaling, leads to elevated hiPSCs derived cardiomyocyte cell divisions and increased grafting rate together with improved cardiac function following MI (Fan et al., 2020).